Accumulating evidences have revealed the critical role of NLRP3 inflammasome in the development of several liver diseases including NAFLD, liver fibrosis and acute liver injury (Al Mamun et al., 2020). Here, NLRP3 is linked to metabolic dysfunction-associated steatotic liver disease.